ArticleFrontiers in oncology2023

Survival benefit with checkpoint inhibitors versus chemotherapy is modified by brain metastases in patients with recurrent small cell lung cancer.

Friederike C Althoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.